Table II.
Demographic data for all UCL reconstruction and repair from 2010 to 2019 showing likelihoods of receiving reconstruction over repair. There were no significant differences in any category except for rural surgical settings in which patients were significantly more likely to undergo reconstruction.
| Total | Repair | Reconstruction | Chi-square P value | Odds ratio | OR 95% CI | |
|---|---|---|---|---|---|---|
| Procedure | ||||||
| Scope | 102 | 22 | 80 | .092 | 1.521 | 0.937-2.468 |
| PRP | 29 | 9 | 20 | .837 | 0.906 | 0.410-2.004 |
| Ulnar nerve | 429 | 114 | 315 | .217 | 1.176 | 0.010-1.504 |
| Gender | ||||||
| Male | 1445 | 417 | 1028 | .746 | 1.066 | 0.778-1.460 |
| Female | 212 | 64 | 148 | - | - | - |
| Race | ||||||
| Hispanic | 210 | 59 | 151 | .808 | 1.045 | 0.757-1.441 |
| White | 1169 | 337 | 832 | .813 | 1.032 | 0.818-1.300 |
| Black | 48 | 13 | 35 | .872 | 1.104 | 0.579-2.105 |
| Asian | 13 | 6 | 7 | .218 | 0.474 | 0.158-1.417 |
| Native American | 2 | 1 | 1 | 1.000 | 0.408 | 0.025-6.541 |
| Other | 429 | 125 | 304 | .951 | 0.992 | 0.779-1.264 |
| Age (y) | ||||||
| <18 | 563 | 150 | 413 | .138 | 1.192 | 0.950-1.495 |
| 18-44 | 995 | 300 | 695 | .225 | 0.869 | 0.774-1.058 |
| 45-64 | 87 | 28 | 59 | .554 | 0.853 | 0.538-1.356 |
| 65+ | 17 | 4 | 13 | .791 | 1.331 | 0.432-4.103 |
| City | ||||||
| Metro | 1253 | 366 | 887 | .303 | 0.808 | 0.551-1.184 |
| Micro | 80 | 25 | 55 | .612 | 0.881 | 0.541-1.434 |
| Rural | 76 | 14 | 62 | .05∗ | 1.838∗ | 1.017-3.322∗ |
| Payor status | ||||||
| Private | 1463 | 425 | 1038 | .934 | 0.98 | 0.707-1.360 |
| Medicare | 19 | 6 | 13 | 1.000 | 0.884 | 0.334-2.339 |
| Medicaid | 46 | 10 | 36 | .324 | 1.485 | 0.731-3.017 |
| Worker's comp | 90 | 28 | 62 | .720 | 0.899 | 0.568-1.424 |
| Self-pay | 37 | 11 | 26 | 1.000 | 0.965 | 0.473-1.968 |
| Other | 7 | 2 | 5 | 1.000 | 1.021 | 0.197-5.282 |
| Setting | ||||||
| ASC | 1100 | 311 | 789 | .361 | 1.11 | 0.888-1.386 |
| Academic | 206 | 63 | 143 | .623 | 0.917 | 0.668-1.260 |
CI, confidence interval; OR, odds ratio; PRP, platelet-rich plasma; UCL, ulnar collateral ligament.
P≤.05